Open Access
BIO Web Conf.
Volume 75, 2023
The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2023)
Article Number 05015
Number of page(s) 9
Section Big Data for Public Health Policy
Published online 15 November 2023
  • NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet, (27), 15–30 (2016). [Google Scholar]
  • MK. Kramer, RG. Miller, LM. Siminerio. Evaluation of a community Diabetes Prevention Program delivered by diabetes educators in the United States: one-year follow up. Diabetes Res Clin Pract. (3), 49-52 (2014). [Google Scholar]
  • Diabetes Prevention Program Research Group, WC. Knowler, SE. Fowler, RF. Hamman, CA. Christophi, HJ. Hoffman, AT. Brenneman, JO. Brown-Friday, R. Goldberg, E Venditti, and DM Nathan. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet.,(16), 77–86 (2009). [Google Scholar]
  • M. Bansal, M. Shah, B. Reilly, S. Willman, M. Gill, FR. Kaufman. Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes. Appl Health Econ Health Policy, (6), 75–84, (2018). [Google Scholar]
  • WC. Knowler, E. Barrett-Connor, SE. Fowler, RF. HammaN, JM. Lachin, EA. Walker, and DM. Nathan. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med., (6), 393–403, (2002). [Google Scholar]
  • JH. Shubrook, W. Chen, A. Lim. Evidence for the Prevention of Type 2 Diabetes Mellitus. J Am Osteopath Assoc. (11), 30–38, (2018). [Google Scholar]
  • WH. Herman. The cost-effectiveness of diabetes prevention: results from the Diabetes Prevention Program and the Diabetes Prevention Program Outcomes Study. Clin Diabetes Endocrinol, (12)19, (2015). [Google Scholar]
  • S. Roberts, E. Barry, D. Craig, M. Airoldi, G. Bevan, T. Greenhalgh. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open. (11):017-184, 2017. [Google Scholar]
  • Taylor R, Valabhji J, Aveyard P, Paul D. Prevention and reversal of Type 2 diabetes: highlights from a symposium at the 2019 Diabetes UK Annual Professional Conference. Diabet Med. (3), 59–65, (2019). [Google Scholar]
  • LM. Davis, C. Coleman, J. Kiel, J. Rampolla, T. Hutchisen, L. Ford, WS. Andersen, and AH. Mitola, Efficacy of a meal replacement diet plan compared to a food-based diet plan after a period of weight loss and weight maintenance: a randomized controlled trial. Nutr J. Mar (11), 9:11, (2010). [CrossRef] [Google Scholar]
  • X. Zhuo, P. Zhang, HS. Kahn, BH. Bardenheier, R. Li, EW. Gregg. Change in medical spending attributable to diabetes: national data from 1987 to. Diabetes Care 2011. (4), 81–87 (2015). [Google Scholar]
  • J. Cawley, C. Meyerhoefer, A. Biener, M. Hammer, N. Wintfeld. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. Pharmacoeconomics. (7), 7–22 (2015.) [Google Scholar]
  • J. Cawley, C. Meyerhoefer. The medical care costs of obesity: an instrumental variables approach. J Health Econ., (1), 19–30, (2012). [Google Scholar]
  • WH. Herman, TJ. Hoerger, M. Brandle, K. Hicks, S. Sorensen, P. Zhang, RF. Hamman, RT, Ackermann, MM. Engelgau, and RE. Ratner. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. (5), 23–32, (2005). [Google Scholar]
  • JD. Hirsch, M. Bounthavong, A. Arjmand, DR. Ha, CL. Cadiz, A. Zimmerman, H. Ourth, AP. Morreale, SV. Edelman, and MM. Candis. Estimated Cost Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management “Tune-Up” Clinic. J Manag Care Spec Pharm. (3), 18–26 (2017). [Google Scholar]
  • MJ. Page, JE. McKenzie, PM. Bossuyt, I. Boutron, TC. Hoffmann, CD. Mulrow, L. Shamseet, JM. Tetzlaff, EA. Akl, SE. Brennann, R. Chou, J. Glanville, JM. Grimshaw, A. Hróbjartsson, MM. Lalu, T. Li, EW. Loder, EM. Wilson, S. McDonald, LA. McGuinness, LA. Stewart, J. Thomas, AC. Tricco, VA, Welch, P. Whiting, D. Moher. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021 Mar 29;10(1):89. [CrossRef] [PubMed] [Google Scholar]
  • CM. Horstman, DH. Ryan, LJ. Aronne, CM. Apovian, JP Foreyt, HM. Tuttle, and DA. Williamson. Return on Investment: Medical Savings of an Employer Sponsored Digital Intensive Lifestyle Intervention, Weight Loss. Obesity (Silver Spring). (4):54–61, (2021). [Google Scholar]
  • ND. White, TL. Lenz, MZ. Skrabal, JJ. Skradski, L. Lipari. Long-Term Outcomes of a Cardiovascular and Diabetes Risk-Reduction Program Initiated by a Self-Insured Employer. Am Health Drug Benefits. (4):77–83, (2018). [Google Scholar]
  • T. Khan, S. Tsipas, G. Wozniak. Medical Care Expenditures for Individuals with Prediabetes: The Potential Cost Savings in Reducing the Risk of Developing Diabetes. Popul Health Manag. 2017 Oct 1;20(5):389–96. [CrossRef] [PubMed] [Google Scholar]
  • NX. Thanh, K. Dmytruk, P. O’Connell, E. Rogers, D. Fillier, JM. MacRae, C. Thomas, C. Rennie, C. Eitzenberger, C. Newman, B. Match, C. Thompson, J. Nhan and T. Wasylak. Return on investment of the diabetes foot care clinical pathway implementation in Alberta, Canada. Diabetes Res Clin Pract. (165), 108-241, (2020). [Google Scholar]
  • AC. Sylvetsky, SL. Edelstein, G. Walford, EJ. Boyko, ES. Horton, UN. Ibebuogo. A highcarbohydrate, high-fiber, low-fat diet result in weight loss among adults at highriskog type 2 diabetes. The Journal of Nutrition. (11), 20602066, (2016). [Google Scholar]
  • LA. Sanchez. Applied pharmacoeconomics: evaluation and use of pharmacoeconomic data from the literature. Am J Health Syst Pharm. (16), 38–40, (1999). [Google Scholar]
  • BA. Kash, SH. Lin, J. Baek, RL. Ohsfeld. The diabetes management education program in south texas: an economic an clinical impact analysis. Front Public Helath (5), 345, (2017). [CrossRef] [Google Scholar]
  • C. Thomas, S. Sadler, P. Breeze, H. Squires, M. Gillett, A. Brennan. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open. (8), 149-153, (2017). [Google Scholar]
  • FF. Jiao, CSC. Fung, EYF. Wan, AKC. Chan, SM, McGhee, RLP. Kwok. Five-years cost-effective of the multidisciplinary risk assesment and management programme diabetes mellitus (RAMPDM). American Diabetes Association. (2), 250-257, (2018). [Google Scholar]
  • TL. Michaud, W. You, KE. Wilson, D. Su, TJ. McGuire, FA. Almeida, AL. Bayer, and PA. Estabrooks. Cost effectiveness and return on investment of a scalable community weight loss intervention. Prev Med. (105), 295–303, (2017). [CrossRef] [PubMed] [Google Scholar]
  • W. Su, F. Chen, TM. Dall, W. Iacobucci, L. Perreault. Return on Investment for Digital Behavioral Counseling in Patients With Prediabetes and Cardiovascular Disease. Prev Chronic Dis. (13), 150-357, (2016). [Google Scholar]
  • World Health Organization, Programme UND. Non-communicable disease prevention and control: a guidance note for investment cases [Internet]. World Health Organization; 2019 [cited 2023 Jun 4]. [Google Scholar]
  • Agency for Healthcare Research and Quality. Return on Investment Tools.” Agency for Healthcare Research and Quality. [Internet]. Agency for Healthcare Research and Quality [cited 2023 Jun 1]. [Google Scholar]
  • MB. Weber, MM. Hennink, KMV. Narayan. Tailoring lifestyle programmes for diabetes prevention for US South Asians. Fam Med Community Health. (2), 29-35, (2020). [Google Scholar]
  • P. Balagopal, N. Kamalamma, TG. Patel, R. Misra. A community-based participatory diabetes prevention and management intervention in rural India using community health workers. Diabetes Educ. (6), 22–34, (2012). [Google Scholar]
  • M. Matsushita, A. Muramoto, E. Nomura, Y. Eguchi, A. Kato, Y. Sano, M. Kabayama, M. Arakawa, Y. Oguma, D. Yabe, M. Matsunaga, H. Yatsuya, H. Arima dan K. Tsushita. The Smart Life Stay (SLS) program: effects of a lifestyle intervention program in combination with health tourism and health guidance for type 2 diabetes. Nutr Diabetes. (1), 33-40, (2020). [CrossRef] [PubMed] [Google Scholar]
  • ML. Smith, L. Zhong, S. Lee, SD. Towne, MG. Ory. Effectiveness and economic impact of a diabetes education program among adults with type 2 diabetes in South Texas. BMC Public Health. (21), 16-46, (2021). [PubMed] [Google Scholar]
  • CC. Sweet, CB. Jasik, A. Diebold, A. DuPuis, B. Jendretzke. Cost Savings and Reduced Health Care Utilization Associated with Participation in a Digital Diabetes Prevention Program in an Adult Workforce Population. J Health Econ Outcomes Res. (2), 39–47, (2020). [Google Scholar]
  • AJ. Vickers, B. Van Calster, EW. Steyerberg. Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ.(3), 52-66 (2016). [Google Scholar]
  • RM. Turner, Q. Ma, K. Lorig, J. Greenberg, AR. DeVries. Evaluation of a Diabetes SelfManagement Program: Claims Analysis on Comorbid Illnesses, Health Care Utilization, and Cost. J Med Internet Res. (6), 207-211, (2018). [Google Scholar]
  • SH. Golden, N. Maruthur, N. Mathioudakis, E. Spanakis, D. Rubin, M. Zilbermint and FH. Briggs. The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes. Curr Diab Rep. (7), 51-60, (2017). [CrossRef] [PubMed] [Google Scholar]
  • TP. Gilmer, PJ. O’Connor, WA. Rush, AL. Crain, RR. Whitebird, AM. Hanson, LI. Solberg. Predictors of health care costs in adults with diabetes. Diabetes Care. (1), 59–64, (2005). [CrossRef] [PubMed] [Google Scholar]
  • H. Heun-Johnson, KV. Zuluaga, M. Menchine, S. Starkey, RF. David, S. Seabury. Assessing the Use of Data Systems to Estimate Return-on-Investment of Behavioral Healthcare Interventions: Opportunities and Barriers. J Behav Health Serv Res. (1), 80–94, (2023). [CrossRef] [PubMed] [Google Scholar]
  • P. Soewondo, A. Ferrario, DL Tahapary. Challenges in diabetes management in Indonesia: a literature review. Global Health. 2013 Dec 3;9:63. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.